Inhibition of the NKp30 activating receptor by pp65 of human cytomegalovirus

Nature Immunology

Volumn 6, Issue 5, 2005, Pages 515-523

  Arnon, Tal I ^a   Achdout, Hagit ^a   Levi, Ofer ^a   Markel, Gal ^a   Saleh, Nivin ^b   Katz, Gil ^a   Gazit, Roi ^a   Gonen Gross, Tsufit ^a   Hanna, Jacob ^a   Nahari, Efrat ^b   Porgador, Angel ^c   Honigman, Alik ^a   Plachter, Bodo ^d   Mevorach, Dror ^b   Wolf, Dana G ^b   Mandelboim, Ofer ^a  

^a HEBREW UNIVERSITY   (Israel)

^b HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^c BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^d JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CELL RECEPTOR; CYTOMEGALOVIRUS ANTIGEN PP65; MEMBRANE RECEPTOR; PROTEIN NKP30; UNCLASSIFIED DRUG; CELL SURFACE RECEPTOR; CYTOMEGALOVIRUS MATRIX PROTEIN 65KDA; IMMUNOGLOBULIN FC FRAGMENT; IMMUNOGLOBULIN RECEPTOR; MATRIX PROTEIN; MEMBRANE PROTEIN; NKP30 PROTEIN, HUMAN; PHOSPHOPROTEIN;

ARTICLE; CELL ACTIVATION; CELL ACTIVITY; CELL KILLING; CONTROLLED STUDY; CYTOMEGALOVIRUS; CYTOTOXICITY; DRUG INHIBITION; HUMAN; HUMAN CELL; NATURAL KILLER CELL; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN INTERACTION; ANIMAL; CELL CULTURE; DRUG ANTAGONISM; DRUG EFFECT; GENE EXPRESSION REGULATION; IMMUNOLOGY; KINETICS; METABOLISM; MOUSE; PHYSIOLOGY;

ANIMALS; CELLS, CULTURED; CYTOMEGALOVIRUS; CYTOTOXICITY, IMMUNOLOGIC; GENE EXPRESSION REGULATION; HUMANS; IMMUNOGLOBULIN FC FRAGMENTS; KILLER CELLS, NATURAL; KINETICS; MEMBRANE GLYCOPROTEINS; MICE; PHOSPHOPROTEINS; PROTEIN BINDING; RECEPTORS, CELL SURFACE; RECEPTORS, IMMUNOLOGIC; VIRAL MATRIX PROTEINS;

EID: 18244367112     PISSN: 15292908     EISSN: 15292916     Source Type: Journal    
DOI: 10.1038/ni1190     Document Type: Article

References (44)

1. Carayannopoulos, L.N. & Yokoyama, W.M. Recognition of infected cells by natural killer cells. Curr. Opin. Immunol. 16, 26-33 (2004).
2. Karre, K. How to recognize a foreign submarine. Immunol. Rev. 155, 5-9 (1997).
3. Biassoni, R. et al. Human natural killer cell receptors: insights into their molecular function and structure. J. Cell. Mol. Med. 7, 376-387 (2003).
4. Moretta, A., Bottino, C., Mingari, M.C., Biassoni, R. & Moretta, L. What is a natural killer cell? Nat. Immunol. 3, 6-8 (2002).
5. Mandelboim, O. et al. Recognition of haemagglutinins on virus-infected cells by NKp46 activates lysis by human NK cells. Nature 409, 1055-1060 (2001).
6. Arnon, T.I. et al. The mechanisms controlling the recognition of tumor- and virus-infected cells by NKp46. Blood 103, 664-672 (2004).
7. Arnon, T.I. et al. Recognition of viral hemagglutinins by NKp44 but not by NKp30. Eur. J. Immunol. 31, 2680-2689 (2001).
8. Cerwenka, A. & Lanier, L.L. NKG2D ligands: unconventional MHC class I-like molecules exploited by viruses and cancer. Tissue Antigens 61, 335-343 (2003).
9. Sutherland, C.L., Chalupny, N.J. & Cosman, D. The UL16-binding proteins, a novel family of MHC class I-related ligands for NKG2D, activate natural killer cell functions. Immunol. Rev. 181, 185-192 (2001).
10. Biron, C.A., Nguyen, K.B., Pien, G.C., Cousens, L.P. & Salazar-Mather, T.P. Natural killer cells in antiviral defense: function and regulation by innate cytokines. Annu. Rev. Immunol. 17, 189-220 (1999).
11. Kano, Y. & Shiohara, T. Current understanding of cytomegalovirus infection in immunocompetent individuals. J. Dermatol. Sci. 22, 196-204 (2000).
12. Orange, J.S., Fassett, M.S., Koopman, L.A., Boyson, J.E. & Strominger, J.L. Viral evasion of natural killer cells. Nat. Immunol. 3, 1006-1012 (2002).
13. Carr, W.H., Little, A.M., Mocarski, E. & Parham, P. NK cell-mediated lysis of autologous HCMV-infected skin fibroblasts is highly variable among NK cell clones and polyclonal NK cell lines. Clin. Immunol. 105, 126-140 (2002).
14. Cerboni, C. et al. Human cytomegalovirus strain-dependent changes in NK cell recognition of infected fibroblasts. J. Immunol. 164, 4775-4782 (2000).
15. Brown, M.G. et al. Vital involvement of a natural killer cell activation receptor in resistance to viral infection. Science 292, 934-937 (2001).
16. Arase, H., Mocarski, E.S., Campbell, A.E., Hill, A.B. & Lanier, L.L. Direct recognition of cytomegalovirus by activating and inhibitory NK cell receptors. Science 296, 1323-1326 (2002).
17. Karre, K. Clever, cleverer, cleverest. Nat. Immunol. 3, 505-506 (2002).
18. Dunn, C. et al. Human cytomegalovirus glycoprotein UL16 causes intracellular sequestration of NKG2D ligands, protecting against natural killer cell cytotoxicity. J. Exp. Med. 197, 1427-1439 (2003).
19. Varnum, S.M. et al. Identification of proteins in human cytomegalovirus (HCMV) particles: the HCMV proteome. J. Virol. 78, 10960-10966 (2004).
20. Markel, G. et al. Pivotal role of CEACAM1 protein in the inhibition of activated decidual lymphocyte functions. J. Clin. Invest. 110, 943-953 (2002).
21. Sanchez, V., Angeletti, P.C., Engler, J.A. & Britt, W.J. Localization of human cytomegalovirus structural proteins to the nuclear matrix of infected human fibroblasts. J. Virol. 72, 3321-3329 (1998).
22. Schmolke, S., Kern, H.F., Drescher, P., Jahn, G. & Plachter, B. The dominant phosphoprotein pp65 (UL83) of human cytomegalovirus is dispensable for growth in cell culture. J. Virol. 69, 5959-5968 (1995).
23. Wang, E.G. et al. UL40-mediated NK evasion during productive infection with human cytomegalovirus. Proc. Natl. Acad. Sci. USA 99, 7570-7575 (2002).
24. Krosky, P.M. et al. The human cytomegalovirus UL44 protein is a substrate for the UL97 protein kinase. J. Virol. 77, 7720-7727 (2003).
25. + T cells by dendritic cells. J. Virol. 74, 10018-10024 (2000).
26. Van Zanten, J. et al. Dendritic cells present an intracellular viral antigen derived from apoptotic cells and induce a T-cell response. Scand. J. Immunol. 56, 254-259 (2002).
27. Long, E.O. Tumor cell recognition by natural killer cells. Semin. Cancer Biol. 12, 57-61 (2002).
28. Pende, D. et al. Identification and molecular characterization of NKp30, a novel triggering receptor involved in natural cytotoxicity mediated by human natural killer cells. J. Exp. Med. 190, 1505-1516 (1999).
29. Ferlazzo, G. et al. Human dendritic cells activate resting natural killer (NK) cells and are recognized via the NKp30 receptor by activated NK cells. J. Exp. Med. 195, 343-351 (2002).
30. Hahn, G., Jores, R. & Mocarski, E.S. Cytomegalovirus remains latent in a common precursor of dendritic and myeloid cells. Proc. Natl. Acad. Sci. USA 95, 3937-3942 (1998).
31. De Maria, A. et al. The impaired NK cell cytolytic function in viremic HIV-1 infection is associated with a reduced surface expression of natural cytotoxicity receptors (NKp46, NKp30 and NKp44). Eur. J. Immunol. 33, 2410-2418 (2003).
32. Markel, G. et al. The mechanisms controlling NK cell autoreactivity in TAP2-deficient patients. Blood 103, 1770-1778 (2004).
33. Tanaka, N. et al. Expression of tegument protein pp65 of human cytomegalovirus (CMV) and its application to the analysis of viral-specific cellular immunity in CMV-infected individuals. Arch. Virol. 147, 2405-2417 (2002).
34. Ohlin, M. et al. Human antibody reactivity against the lower matrix protein (pp65) produced by cytomegalovirus. Clin. Diagn. Lab. Immunol. 2, 325-329 (1995).
35. Muller, T.F. et al. Pattern and persistence of the epitope-specific IgM response against human cytomegalovirus in renal transplant patients. J. Clin. Virol. 24, 45-56 (2002).
36. Odeberg, J., Plachter, B., Branden, L. & Soderberg-Naucler, C. Human cytomegalovirus protein pp65 mediates accumulation of HLA-DR in lysosomes and destruction of the HLA-DR α-chain. Blood 101, 4870-4877 (2003).
37. Browne, E.P. & Shenk, T. Human cytomegalovirus UL83-coded pp65 virion protein inhibits antiviral gene expression in infected cells. Proc. Natl. Acad. Sci. USA 100, 11439-11444 (2003).
38. Abate, D.A., Watanabe, S. & Mocarski, E.S. Major human cytomegalovirus structural protein pp65 (ppUL83) prevents interferon response factor 3 activation in the interferon response. J. Virol. 78, 10995-11006 (2004).
39. Wills, M.R. et al. The human cytotoxic T-lymphocyte (CTL) response to cytomegalovirus is dominated by structural protein pp65: frequency, specificity, and T-cell receptor usage of pp65-specific CTL. J. Virol. 70, 7569-7579 (1996).
40. Spaggiari, G.M. et al. NK cell-mediated lysis of autologous antigen-presenting cells is triggered by the engagement of the phosphatidylinositol 3-kinase upon ligation of the natural cytotoxicity receptors NKp30 and NKp46. Eur. J. Immunol. 31, 1656-1665 (2001).
41. Baniyash, M. TCR ζ-chain downregulation: curtailing an excessive inflammatory immune response. Nat. Rev. Immunol. 4, 675-687 (2004).
42. Wolf, D.G. et al. Emergence of late cytomegalovirus central nervous system disease in hematopoietic stem cell transplant recipients. Blood 101, 463-465 (2003).
43. Verbovetski, I. et al. Opsonization of apoptotic cells by autologous iC3b facilitates clearance by immature dendritic cells, down-regulates DR and CD86, and up-regulates CC chemokine receptor 7. J. Exp. Med. 196, 1553-1561 (2002).
44. Fridmann, Y., Kafri, G., Danziger, O. & Horovitz, A. Dissociation of the GroEL-GroES asymmetric complex is accelerated by increased cooperativity in ATP binding to the GroEL ring distal to GroES. Biochemistry 41, 5938-5944 (2002).